Renal tumors represent a heterogeneous group of lesions with varying malignant potential, prognoses, and treatment requirements [1]. Accurate preoperative characterization of these tumors is critical to guide management strategies, especially given the growing emphasis on nephron-sparing surgery and personalized care [2]. Whilecontrast-enhanced computed tomography (CT)remains the mainstay of imaging for renal masses, its diagnostic accuracy in reliably distinguishing between histologic subtypes …